Suppressive effects of selected food phytochemicals on CD74 expression in NCI-N87 gastric carcinoma cells

Journal of Clinical Biochemistry and Nutrition

Volumn 43, Issue 2, 2008, Pages 109-117

  Sekiguchi, Hirotaka ^a   Washida, Kazuto ^b   Murakami, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

^b The Nara Prefectural Agricultural Experiment Station   (Japan)

Author keywords

Adhesion; Bergamottin; CD74; Cell based ELISA; Helicobacter pylori

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; ANTINEOPLASTIC AGENT; ASCORBIC ACID; AURAPTENE; BARBAREA VERNA EXTRACT; BENZYL ISOTHIOCYANATE; BERGAMOTTIN; BUTENYL ISOTHIOCYANATE; CAFFEINE; CATECHIN; CD74 ANTIGEN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FERULIC ACID; GALLIC ACID; GENISTEIN; GLUCONAPIN; GLUCONASTURTIIN; LUTEOLIN; LYMPHOCYTE ANTIGEN; MESSENGER RNA; NOBILETIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; RUTOSIDE; SILYMARIN; TANGERETIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BARBAREA VERNA; CANCER CELL CULTURE; CANCER INHIBITION; CITRUS FRUIT; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IC 50; LC 50; MEDICINAL PLANT; STOMACH CARCINOMA;

CITRUS; HELICOBACTER PYLORI;

EID: 54949088956     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2008054     Document Type: Article

References (64)

1. Parsonnet, J., Friedman, G.D., Vandersteen, D.P., Chang, Y., Vogelman, J.H., Orentreich, N., and Sibley, R.K.: Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med., 325, 1127-1131, 1991.
2. Nomura, A., Stemmermann, G.N., Chyou, P.H., Kato, I., Perez-Perez, G.I., and Blaser, M.J.: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med., 325, 1132-1136, 1991.
3. Infection with Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum., 61, 177-240, 1994.
4. Debets-Ossenkopp, Y.J., Sparrius, M., Kusters, J.G., Kolkman, J.J., and Vandenbroucke-Grauls, C.M.: Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol. Lett., 142, 37-42, 1996.
5. Maeda, S., Yoshida, H., Matsunaga, H., Ogura, K., Kawamata, O., Shiratori, Y., and Omata, M.: Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay. J. Clin. Microbiol., 38, 210-214, 2000.
6. Matsubara, S., Shibata, H., Ishikawa, F., Yokokura, T., Takahashi, M., Sugimura, T., and Wakabayashi, K.: Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochem. Biophys. Res. Commun., 310, 715-719, 2003.
7. Iimuro, M., Shibata, H., Kawamori, T., Matsumoto, T., Arakawa, T., Sugimura, T., and Wakabayashi, K.: Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett., 187, 61-68, 2002.
8. Hatakeyama, M.: Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer, 4, 688-694, 2004.
9. Beswick, E.J., Pinchuk, I.V., Minch, K., Suarez, G., Sierra, J.C., Yamaoka, Y., and Reyes, V.E.: The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect. Immun., 74, 1148-1155, 2006.
10. Beswick, E.J., Suarez, G., and Reyes, V.E.: H. pylori and host interactions that influence pathogenesis. World J. Gastroenterol., 12, 5599-5605, 2006.
11. Marshall, B.J., Barrett, L.J., Prakash, C., McCallum, R.W., and Guerrant, R.L.: Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology, 99, 697-702, 1990.
12. Beswick, E.J., Bland, D.A., Suarez, G., Barrera, C.A., Fan, X., and Reyes, V.E.: Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect. Immun., 73, 2736-2743, 2005.
13. Murakami, A., Ohura, S., Nakamura, Y., Koshimizu, K., and Ohigashi, H.: 1′-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin. Oncology, 53, 386-391, 1996.
14. Murakami, A., Takahashi, M., Jiwajinda, S., Koshimizu, K., and Ohigashi, H.: Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation. Biosci. Biotechnol. Biochem., 63, 1811-1812, 1999.
15. Murakami, A., Kuki, W., Takahashi, Y., Yonei, H., Nakamura, Y., Ohto, Y., Ohigashi, H., and Koshimizu, K.: Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes. Jpn. J. Cancer Res., 88, 443-452, 1997.
16. Murakami, A., Nakamura, Y., Torikai, K., Tanaka, T., Koshiba, T., Koshimizu, K., Kuwahara, S., Takahashi, Y., Ogawa, K., Yano, M., Tokuda, H., Nishino, H., Mimaki, Y., Sashida, Y., Kitanaka, S., and Ohigashi, H.: Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res., 60, 5059-5066, 2000.
17. Murakami, A., Ishida, H., Kobo, K., Furukawa, I., Ikeda, Y., Yonaha, M., Aniya, Y., and Ohigashi, H.: Suppressive effects of Okinawan food items on free radical generation from stimulated leukocytes and identification of some active constituents: implications for the prevention of inflammation-associated carcinogenesis. Asian Pac. J. Cancer Prev., 6, 437-448, 2005.
18. Barillari, J., Gueyrard, D., Rollin, P., and Iori, R.: Barbarea verna as a source of 2-phenylethyl glucosinolate, precursor of cancer chemopreventive phenylethyl isothiocyanate. Fitoterapia, 72, 760-764, 2001.
19. Mosmann, T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63, 1983.
20. Murakami, A., Shigemori, T., and Ohigashi, H.: Zingiberaceous and citrus constituents, 1′-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action. J. Nutr., 135, 2987S-2992S, 2005.
21. Kwon, K.H., Murakami, A., and Ohigashi, H.: Suppressive effects of natural and synthetic agents on dextran sulfate sodium-induced interleukin-1beta release from murine peritoneal macrophages. Biosci. Biotechnol. Biochem., 68, 436-439, 2004.
22. Kim, H.W., Murakami, A., Williams, M.V., and Ohigashi, H.: Suppressive effects of selected antioxidants on the activated leukocytes-induced mutagenesis in the co-culture assay systems. Biosci. Biotechnol. Biochem., 68, 238-242, 2004.
23. Hennig, E.E., Mernaugh, R., Edl, J., Cao, P., and Cover, T.L.: Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA. Infect. Immun., 72, 3429-3435, 2004.
24. Unemo, M., Aspholm-Hurtig, M., Ilver, D., Bergstrom, J., Boren, T., Danielsson, D., and Teneberg, S.: The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J. Biol. Chem., 280, 15390-15397, 2005.
25. Odenbreit, S., Faller, G., and Haas, R.: Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. Int. J. Med. Microbiol., 292, 247-256, 2002.
26. Fan, X., Gunasena, H., Cheng, Z., Espejo, R., Crowe, S.E., Ernst, P.B., and Reyes, V.E.: Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J. Immunol., 165, 1918-1924, 2000.
27. Starlets, D., Gore, Y., Binsky, I., Haran, M., Harpaz, N., Shvidel, L., Becker-Herman, S., Berrebi, A., and Shachar, I.: Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood, 107, 4807-4816, 2006.
28. Binsky, I., Haran, M., Starlets, D., Gore, Y., Lantner, F., Harpaz, N., Leng, L., Goldenberg, D.M., Shvidel, L., Berrebi, A., Bucala, R., and Shachar, I.: IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc. Natl. Acad. Sci. U. S. A., 104, 13408-13413, 2007.
29. Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Iwashige, H., Aridome, K., Hokita, S., and Aikou, T.: Invariant chain expression in gastric cancer. Cancer Lett., 168, 87-91, 2001.
30. Young, A.N., Amin, M.B., Moreno, C.S., Lim, S.D., Cohen, C., Petros, J.A., Marshall, F.F., and Neish, A.S.: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol., 158, 1639-1651, 2001.
31. Meyer-Siegler, K.L., Leifbeit, E.C., and Vera, P.L.: Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer, 4, 34, 2004.
32. Chamuleau, M.E., Souwer, Y., Van Ham, S.M., Zevenbergen, A., Westers, T.M., Berkhof, J., Meijer, C.J., van de Loosdrecht, A.A., and Ossenkoppele, G.J.: Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome. Cancer Res., 64, 5546-5550, 2004.
33. Stein, R., Mattes, M.J., Cardillo, T.M., Hansen, H.J., Chang, C.H., Burton, J., Govindan, S., and Goldenberg, D.M.: CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin. Cancer Res., 13, 5556s-5563s, 2007.
34. Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T., and Bucala, R.: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. U. S. A., 93, 7849-7854, 1996.
35. Calandra, T. and Roger, T.: Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol., 3, 791-800, 2003.
36. Roger, T., David, J., Glauser, M.P., and Calandra, T.: MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature, 414, 920-924, 2001.
37. Kleemann, R., Hausser, A., Geiger, G, Mischke, R., Burger-Kentischer, A., Flieger, O., Johannes, F.J., Roger, T., Calandra, T., Kapurniotu, A., Grell, M., Finkelmeier, D., Brunner, H., and Bernhagen, J.: Intracellular action of the cytokine MfF to modulate AP-1 activity and the cell cycle through Jab1. Nature, 408, 211-216, 2000.
38. Hudson, J.D., Shoaibi, M.A., Maestro, R., Carnero, A., Hannon, G.J., and Beach, D.H.: A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med., 190, 1375-1382, 1999.
39. Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J.W., Lolis, E., Noble, P., Knudson, W., and Bucala, R.: CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity, 25, 595-606, 2006.
40. Hayashi, S., Sugiyama, T., Amano, K., Isogai, H., Isogai, E., Aihara, M., Kikuchi, M., Asaka, M., Yokota, K., Oguma, K., Fujii, N., and Hirai, Y.: Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells. Antimicrob. Agents Chemother., 42, 1895-1899, 1998.
41. Sun, Y.Q., Girgensone, I., Leanderson, P., Petersson, F., and Borch, K.: Effects of antioxidant vitamin supplements on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter, 10, 33-42, 2005.
42. Takeda, K., Utsunomiya, H., Kakiuchi, S., Okuno, Y., Oda, K., Inada, K., Tsutsumi, Y., Tanaka, T., and Kakudo, K.: Citrus auraptene reduces Helicobacter pylori colonization of glandular stomach lesions in Mongolian gerbils. J. Oleo Sci., 56, 253-260, 2007.
43. Arabski, M., Kazmierczak, P., Wisniewska-Jarosinska, M., Morawiec, Z., Morawiec-Bajda, A., Klupinska, G., Drzewoski, J., Chojnacki, J., and Blasiak, J.: Helicobacter pylori infection can modulate the susceptibility of gastric mucosa cells to MNNG. Cell Mol. Biol. Lett., 11, 570-578, 2006.
44. He, K., Iyer, K.R., Hayes, R.N., Sinz, M.W., Woolf, T.F., and Hollenberg, P.F.: Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem. Res. Toxicol., 11, 252-259, 1998.
45. Baumgart, A., Schmidt, M., Schmitz, H.J., and Schrenk, D.: Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes. Biochem. Pharmacol., 69, 657-667, 2005.
46. Lin, H.L., Kent, U.M., and Hollenberg, P.F.: The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5. J. Pharmacol. Exp. Ther., 313, 154-164, 2005.
47. Kleiner, H.E., Reed, M.J., and DiGiovanni, J.: Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells. Chem. Res. Toxicol., 16, 415-422, 2003.
48. Cai, Y., Kleiner, H., Johnston, D., Dubowski, A., Bostic, S., Ivie, W., and DiGiovanni, J.: Effect of naturally occurring coumarins on the formation of epidermal DNA adducts and skin tumors induced by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis, 18, 1521-1527, 1997.
49. Murakami, A., Gao, G., Kim, O. K., Omura, M., Yano, M., Ito, C., Furukawa, H., Jiwajinda, S., Koshimizu, K., and Ohigashi, H.: Identification of coumarins from the fruit of Citrus hystrix DC as inhibitors of nitric oxide generation in mouse macrophage RAW 264.7 cells. J. Agric. Food Chem., 47, 333-339, 1999.
50. Kawaii, S., Tomono, Y., Katase, E., Ogawa, K., and Yano, M.: Isolation of furocoumarins from bergamot fruits as HL-60 differentiation-inducing compounds. J. Agric. Food Chem., 47, 4073-4078, 1999.
51. Buiatti, E., Palli, D., Decarli, A., Amadori, D., Avellini, C., Bianchi, S., Biserni, R., Cipriani, F., Cocco, P., Giacosa, A., Marubini, E., Puntoni, R., Vindigni, C., Fraumeni, J. Jr., and Blot, W.: A case-control study of gastric cancer and diet in Italy. Int. J. Cancer, 44, 611-616, 1989.
52. Boeing, H., Frentzel-Beyme, R., Berger, M., Berndt, V., Göres, W., Körner, M., Lohmeier, R., Menarcher, A., Männl, H.F., Meinhardt, M., Müller, R., Ostermeier, H., Paul, F., Schwemmle, K., Wagner, K.H., and Wahrendorf, J.: Case-control study on stomach cancer in Germany. Int. J. Cancer, 47, 858-864, 1991.
53. Ramon, J.M., Serra, L., Cerdo, C., and Oromi, J.: Dietary factors and gastric cancer risk. A case-control study in Spain. Cancer, 71, 1731-1735, 1993.
54. Gonzalez, C.A., Pera, G., Agudo, A., Bueno-de-Mesquita, H.B., Ceroti, M., Boeing, H., Schulz, M., Del Giudice, G., Plebani, M., Carneiro, F., Berrino, F., Sacerdote, C., Tumino, R., Panico, S., Berglund, G., Siman, H., Hallmans, G., Stenling, R., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J.R., Allen, N., Key, T.J., Bingham, S., Day, N.E., Linseisen, J., Nagel, G, Overvad, K., Jensen, M.K., Olsen, A., Tjonneland, A., Buchner, F.L., Peeters, P.H., Numans, M.E., Clavel-Chapelon, F., Boutron-Ruault, M.C., Roukos, D., Trichopoulou, A., Psaltopoulou, T., Lund, E., Casagrande, C., Slimani, N., Jenab, M., and Riboli, E.: Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int. J. Cancer, 118, 2559-2566, 2006.
55. Matza, D., Wolstein, O., Dikstein, R., and Shachar, I.: Invariant chain induces B cell maturation by activating a TAF(II)105-NF-kappaB-dependent transcription program. J. Biol. Chem., 276, 27203-27206, 2001.
56. Barrera, C.A., Beswick, E.J., Sierra, J.C., Bland, D., Espejo, R., Mifflin, R., Adegboyega, P., Crowe, S.E., Ernst, P.B., and Reyes, V.E.: Polarized expression of CD74 by gastric epithelial cells. J. Histochem. Cytochem., 53, 1481-1489, 2005.
57. Beswick, E.J., Pinchuk, I.V., Suarez, G., Sierra, J.C., and Reyes, V.E.: Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events. J. Immunol., 176, 6794-6801, 2006.
58. Daun, J.M. and Cannon, J.G.: Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, R1043-1049, 2000.
59. Cao, W.G., Morin, M., Metz, C., Maheux, R., and Akoum, A.: Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFkappaB. Biol. Reprod., 73, 565-570, 2005.
60. Cao, W.G., Morin, M., Sengers, V., Metz, C., Roger, T., Maheux, R., and Akoum, A.: Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB. Hum. Reprod., 21, 421-428, 2006.
61. Nozawa, Y., Nishihara, K., Peek, R.M., Nakano, M., Uji, T., Ajioka, H., Matsuura, N., and Miyake, H.: Identification of a signaling cascade for interleukin-8 production by Helicobacter pylori in human gastric epithelial cells. Biochem. Pharmacol., 64, 21-30, 2002.
62. Kim, J.A., Kim, D.K., Kang, O.H., Choi, Y.A., Park, H.J., Choi, S.C., Kim, T.H., Yun, K.J., Nah, Y.H., and Lee, Y.M.: Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells. Int. Immunopharmacol., 5, 209-217, 2005.
63. Natarajan, K., Manna, S.K., Chaturvedi, M.M., and Aggarwal, B.B.: Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression. Arch. Biochem. Biophys., 352, 59-70, 1998.
64. Eguchi, A., Kaneko, Y., Murakami, A., and Ohigashi, H.: Zerumbone suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells. Biosci. Biotechnol. Biochem., 71, 935-945, 2007.